Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25B | P30305 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 1/20 | 0.33 |
| ▸ | SNCA | P37840 | 1/20 | 0.33 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.33 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.33 |
| ▸ | EHMT1 | Q9H9B1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10533241 | 0.91 | — | — | |
| SCHEMBL9312090 | 0.83 | — | — | |
| SCHEMBL8321788 | 0.82 | — | — | |
| SCHEMBL11311853 | 0.80 | CDC25B (0.31) | CDC25B | |
| SCHEMBL3673944 | 0.79 | — | — | |
| SCHEMBL11039168 | 0.78 | — | — | |
| Pyrazole SCHEMBL28764278 | 0.78 | — | — | |
| Imidazole SCHEMBL28764277 | 0.78 | ALDH1A1 (0.43) | — | |
| SCHEMBL440760 | 0.78 | CDC25B (0.38) | CDC25BIDO1MAOAMAOBAKT1 | |
| SCHEMBL10537369 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3817094-B1 | FUNCTIONAL SEPARATOR, MANUFACTURING METHOD THEREFOR, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2026-01-28 | — | — | EP | claimed |
| EP-3902053-B1 | CARBON HAVING REDOX FUNCTIONAL GROUP-CONTAINING POLYMER LAYER FORMED THEREON, AND SULFUR-CARBON COMPOSITE AND LITHIUM SECONDARY BATTERY INCLUDING SAME | LG ENERGY SOLUTION LTD (KR) | 2025-05-14 | — | — | EP | claimed |
| US-12087940-B2 | Carbon having redox functional group-containing polymer layer formed thereon, and sulfur-carbon composite and lithium secondary battery including same | LG ENERGY SOLUTION, LTD. (KR) | 2024-09-10 | — | — | US | claimed |
| US-11936064-B2 | Functional separator, method for manufacturing the same, and lithium secondary battery comprising the same | LG ENERGY SOLUTION, LTD. (KR) | 2024-03-19 | — | — | US | claimed |
| CN-112514154-B | Functional separator, method for manufacturing the same, and lithium secondary battery comprising the same | 株式会社LG新能源 | 2023-10-13 | — | — | CN | claimed |
| US-20220037650-A1 | CARBON HAVING REDOX FUNCTIONAL GROUP-CONTAINING POLYMER LAYER FORMED THEREON, AND SULFUR-CARBON COMPOSITE AND LITHIUM SECONDARY BATTERY INCLUDING SAME | LG CHEM, LTD. (KR) | 2022-02-03 | — | — | US | claimed |
| EP-3902053-A1 | CARBON HAVING REDOX FUNCTIONAL GROUP-CONTAINING POLYMER LAYER FORMED THEREON, AND SULFUR-CARBON COMPOSITE AND LITHIUM SECONDARY BATTERY INCLUDING SAME | LG Chem, Ltd. (KR) | 2021-10-27 | — | — | EP | claimed |
| US-20210288380-A1 | FUNCTIONAL SEPARATOR, METHOD FOR MANUFACTURING THE SAME, AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | claimed |
| CN-113228352-A | Carbon having polymer layer containing redox functional group formed thereon, and sulfur-carbon composite and lithium secondary battery comprising the same | 株式会社LG化学 | 2021-08-06 | — | — | CN | claimed |
| EP-3817094-A1 | FUNCTIONAL SEPARATOR, MANUFACTURING METHOD THEREFOR, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG CHEM, LTD. (KR) | 2021-05-05 | — | — | EP | claimed |
| CN-112514154-A | Functional separator, method for manufacturing the same, and lithium secondary battery comprising the same | 株式会社LG化学 | 2021-03-16 | — | — | CN | claimed |
| US-20060072444-A1 | Marked article and method of making the same | CITIBANK, N.A., AS COLLATERAL AGENT | 2006-04-06 | — | — | US | claimed |
| WO-1996028570-A1 | A RAPID METHOD OF AND DIAGNOSTIC KIT FOR THE DETECTION OF MICROORGANISMS | XECHEM, INC. (US) | 1996-09-19 | — | — | WO | claimed |
| US-12629632-B2 | Carbon dioxide recovery system and working electrode | DENSO CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| EP-3817094-B1 | FUNCTIONAL SEPARATOR, MANUFACTURING METHOD THEREFOR, AND LITHIUM SECONDARY BATTERY COMPRISING SAME | LG ENERGY SOLUTION LTD (KR) | 2026-01-28 | — | — | EP | disclosed |
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | CARGILL, INCORPORATED (US) | 2026-01-15 | — | — | US | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4540583-A | 1,4-BIS/AMINOETHYL-ANTHRAQUINONES | AMERICAN CYANAMID COMPANY (US) | 1985-09-10 | — | — | US | disclosed |
| US-4027021-A | 1,5-BIS(SUBSTITUTED AMINO)-ANTHRAQUINONES | THE UPJOHN COMPANY (US) | 1977-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260013535-A1 | STEVIOL GLYCOSIDE SOLUBILITY ENHANCERS | TAS2R7, TAS2R31, TAS2R40 | CDC25B 2756/4885IDO1 4751/4885MAOA 4750/4885 |
| US-12629632-B2 | Carbon dioxide recovery system and working electrode | SLC9A2, EPCAM, GJB2 | CDC25B 2432/4885IDO1 4712/4885MAOA 4565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.